Beta thalassaemia is an inherited blood disorder that affects the body’s ability to produce a vital protein called beta-globin, which is essential for making healthy red blood cells and carrying oxygen throughout the body. This genetic condition can range from mild forms that cause no symptoms to severe types requiring lifelong medical care.

Understanding the Global Impact

Beta thalassaemia represents a significant health concern affecting thousands of people worldwide. This blood disorder is particularly common in specific regions of the world, creating distinct patterns in who develops the condition. People from Mediterranean countries, North Africa, the Middle East, India, Central Asia, and Southeast Asia face higher risks of inheriting this condition.^[1][2] The concentration in these geographic areas reflects generations of genetic inheritance patterns within populations.

Thousands of infants are born with beta thalassaemia each year across the globe. The disorder’s prevalence in certain populations has led to it being recognized as a fairly common blood disorder worldwide, though exact numbers vary by region.^[2] This geographic distribution means that some communities carry a higher burden of the disease, making awareness and genetic counseling particularly important in these areas.

The condition does not discriminate by gender, affecting both males and females equally since it follows an autosomal recessive inheritance pattern, which means the genetic change is not linked to sex chromosomes.^[2] Anyone with family history from high-risk geographic regions should be aware of their potential carrier status, especially when planning to have children.

The Root Cause: A Genetic Story

Beta thalassaemia occurs because of changes, also called mutations, in a specific gene known as the HBB gene, which is located on chromosome 11. This gene contains the instructions your body needs to create beta-globin chains, one of two types of protein chains that make up hemoglobin, the iron-rich protein in red blood cells responsible for carrying oxygen.^[1][2] The other protein chain is called alpha-globin, and both must work together to form functional hemoglobin.

Over 200 different mutations have been identified in the beta-globin gene that can cause beta thalassaemia. These mutations primarily affect how the gene is read and translated into the actual protein, impacting transcriptional control, translation, and splicing processes.^[3] Some mutations prevent any beta-globin from being produced at all, a condition referred to as beta-zero thalassaemia. Other mutations allow some beta-globin to be made, but in reduced amounts, called beta-plus thalassaemia.^[2]

The wide variety of possible mutations explains why beta thalassaemia can look so different from one person to another. Within each geographic population, there are unique mutations that are more common. However, approximately 20 different genetic changes make up about 80% of the mutations found worldwide.^[7] This genetic diversity contributes to the challenge of predicting exactly how severe someone’s condition will be based solely on their genetic test results.

Who Is at Risk

The primary risk factor for developing beta thalassaemia is having a family history of the disorder. Since this is a genetic condition, it can only be inherited from parents who carry the changed gene.^[5] If both parents carry one copy of the mutated gene, each of their children has a 25% chance of inheriting two copies and developing a more severe form of the condition. Each child also has a 50% chance of being a carrier like the parents, and a 25% chance of inheriting two normal genes.

People whose ancestors came from Mediterranean countries such as Greece and Italy, North African nations, Middle Eastern regions, India, Central Asia, and Southeast Asia are at higher risk of being carriers.^[2][4] This geographic concentration has developed over many generations. In some of these populations, being a carrier may have provided some protection against malaria, which could explain why the gene persisted in these regions.

If you inherit a changed gene from only one parent and a normal gene from the other parent, you typically develop the milder form called beta thalassaemia minor or trait. However, if you inherit changed genes from both parents, you are much more likely to develop beta thalassaemia intermedia or major, the more serious forms of the condition.^[1] This pattern of inheritance makes genetic counseling valuable for couples, particularly if both partners have ancestry from high-risk regions.

Recognizing the Symptoms

The symptoms of beta thalassaemia vary dramatically depending on which type a person has. Some people experience no symptoms at all, while others face life-threatening complications. The severity of symptoms generally correlates with how much functional hemoglobin the body can produce.

People with beta thalassaemia minor, also called trait, often have no symptoms whatsoever. When symptoms do occur, they are usually very mild and may include slight tiredness or mild anemia, a condition where the body doesn’t have enough healthy red blood cells.^[5] Many people with this form don’t even know they have it unless they undergo blood testing for another reason. Despite feeling fine, their blood tests may show smaller than normal red blood cells.

Beta thalassaemia intermedia causes more noticeable symptoms, though they typically appear later in childhood or even adulthood rather than in infancy. People with this form experience moderate tiredness, weakness, and pale skin due to anemia.^[2] They may also develop slow growth, bone abnormalities where bones become weak or misshapen, and an enlarged spleen, which is an organ that filters blood. The belly may appear swollen, and there is an increased risk of developing abnormal blood clots.^[1]

Beta thalassaemia major, also known as Cooley’s anemia, is the most severe form and causes symptoms that appear within the first two years of life. Babies with this condition often seem especially fussy and get frequent infections.^[1] As they grow, children develop severe anemia leading to extreme fatigue, profound weakness, shortness of breath, frequent headaches, dizziness, and very pale skin. The heart may beat faster than normal, trying to compensate for low oxygen levels, causing heart palpitations where you can feel your heartbeat strongly in your chest.^[1]

Additional symptoms in severe cases include yellowing of the skin and eyes called jaundice, which happens when old red blood cells break down and release a yellow pigment. The urine may appear dark or tea-colored. Children may not gain weight or grow at the expected rate, a condition doctors call failure to thrive.^[2] The face, arms, legs, and other bones may become weak or develop abnormal shapes because the bone marrow expands trying to produce more red blood cells. The spleen, liver, and heart can become enlarged from working overtime, and puberty may be delayed in adolescents.^[1][2]

Prevention and Early Detection

Because beta thalassaemia is an inherited genetic condition, it cannot be prevented in the traditional sense like an infectious disease. However, there are important steps that can help prevent its transmission to future generations and identify the condition early.

The most effective prevention strategy involves genetic counseling before conception. Couples planning to have children, especially those with ancestry from high-risk geographic regions, can undergo genetic testing to determine if they are carriers of the beta thalassaemia gene.^[4] If both partners discover they are carriers, they can discuss their options with a genetic counselor, including the use of donor sperm or eggs, or prenatal testing during pregnancy to determine if the baby has inherited the condition.

Prenatal testing offers expectant parents information about whether their unborn baby has beta thalassaemia. Two main types of prenatal tests are available. Chorionic villus sampling (CVS) involves removing a tiny piece of the placenta, usually around the 11th week of pregnancy, to check for genetic changes.^[12] Amniocentesis tests a sample of the fluid surrounding the baby in the womb, typically performed around the 16th week of pregnancy.^[1][12] These tests can detect the genetic changes during pregnancy, allowing parents and doctors to prepare for specialized care the baby might need after birth.

Many states in the United States now include beta thalassaemia in their newborn screening programs. Infants born in 42 of the 50 states are screened for hemoglobin disorders shortly after birth, which allows for early diagnosis even before symptoms appear.^[7] Early identification means that treatment can begin promptly, potentially preventing some of the serious complications that can develop if the condition goes untreated.

For people already diagnosed with beta thalassaemia, prevention focuses on avoiding complications. This includes keeping up with all recommended vaccinations to prevent infections, as people with thalassaemia face higher infection risks.^[15] Those who have had their spleen removed are considered “high risk” for certain infections and should follow special vaccination schedules for vaccines protecting against Haemophilus influenzae type b (Hib), pneumococcal infections, and meningococcal disease.^[15]

What Happens Inside the Body

Understanding what happens inside the body when someone has beta thalassaemia helps explain why the symptoms occur. The process begins at the genetic level and cascades through several biological systems.

Hemoglobin molecules are made up of four protein subunits working together: typically two beta-globin subunits and two alpha-globin subunits. In beta thalassaemia, mutations in the HBB gene prevent the body from making enough beta-globin chains. Without sufficient beta-globin, the body cannot form adequate amounts of functional hemoglobin.^[2] This shortage means red blood cells cannot develop and mature normally.

The bone marrow, which is the spongy tissue inside bones where blood cells are made, tries to compensate by working harder to produce more red blood cells. However, because these cells lack proper hemoglobin, many of them are defective and die before leaving the bone marrow or shortly after entering the bloodstream. This process, called ineffective erythropoiesis, means that despite the bone marrow’s increased effort, the body still doesn’t have enough healthy, functioning red blood cells.^[11]

The shortage of mature red blood cells leads to anemia, which is why people feel tired, weak, and short of breath. The body’s tissues and organs don’t receive adequate oxygen because there aren’t enough red blood cells carrying hemoglobin to deliver it. The heart must work harder to pump blood, trying to distribute what little oxygen is available, which can cause the rapid heartbeat and heart palpitations that people experience.^[1]

Meanwhile, the alpha-globin chains that are still being produced normally have no beta-globin partners to pair with. These excess alpha-globin chains accumulate and can damage red blood cells, contributing to their premature destruction. This leads to hemolysis, the breaking down of red blood cells, which releases substances that cause jaundice and dark urine.^[4]

As the bone marrow expands trying to make more red blood cells, it can actually change the structure of bones. In children with severe thalassaemia, this expansion can cause characteristic facial features, with bones in the face and skull becoming misshapen. Other bones throughout the body can become thin and brittle, increasing the risk of fractures.^[2]

The spleen, an organ that normally filters old or damaged blood cells from circulation, becomes overworked because so many red blood cells are defective and die prematurely. The spleen enlarges as it tries to keep up with filtering all these abnormal cells, which can cause abdominal swelling and discomfort.^[1] Similarly, the liver may enlarge as it processes the breakdown products of all these dying blood cells.

In people who receive regular blood transfusions to treat severe anemia, another problem develops over time: iron overload. Each unit of transfused blood contains approximately 200 milligrams of elemental iron. The body has no natural way to remove large amounts of excess iron, so it accumulates in organs including the heart, liver, and hormone-producing glands.^[13] Additionally, the anemia and ineffective erythropoiesis cause the body to decrease production of hepcidin, a hormone that normally regulates iron absorption, which allows even more iron to build up.^[13] This iron accumulation can damage these organs and cause them to function poorly, leading to heart failure, liver disease, diabetes, and other hormonal problems.^[2]